WAVE Life Sciences (WVE) Tops Q4 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
RBC Capital on WAVE Life Sciences (WVE): 'We appreciate the progress but remain cautious'
March 6, 2024 4:18 PM ESTRBC Capital analyst Luca Issi reiterated a Sector Perform rating and $5.00 price target on WAVE Life Sciences (NASDAQ: WVE).
The analyst comments "Next data is HD in Q2 and 20% allele specific KD is the bogey for a go/no-go decision and TAK... More



